PharmaBoardroom

Marc-Olivier Geinoz – CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…

Thomas A. Tóth von Kiskér – CEO & Board Member,…

Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player focused on the digestive system,…

Building a Health Data Ecosystem in Switzerland

Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one potential stumbling block is access to and…

Michael Quirmbach – CEO & President, CordenPharma

The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the…

The Long Read: Innovation, Access & Affordability in the USA

A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly all R&D indices related to…

Japan’s Taiho Pharmaceutical: An Oral Chemotherapy Pioneer

Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known player may be Taiho…

Bayer Strategy Head: Big Pharma “Needs to Up its Game”

During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech executives spoke about the changing…

Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for…

When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a historic moment for Turkey's pharma…

Top 5 Polish Pharma Companies

Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Here, we profile the top five…

Market Access in Switzerland: Reimbursement Delays for 76% of New…

Switzerland, rightly regarded as one of the world’s most innovative nations, risks damaging its reputation if innovative new medicines continue to…

René P Buholzer – CEO, Interpharma, Switzerland (September…

Interpharma CEO Dr René P Buholzer outlines the holistic strategy that needs to be put in place to maintain Switzerland’s leading position in…

The Long Read: Belgium – The Multifaceted

Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France,…

Tagged with Pharma,